CRISPR

CRISPR3-gja1b

ID
ZDB-CRISPR-210119-2
Name
CRISPR3-gja1b
Previous Names
None
Target
Sequence
5' - CCAGGCTACAAACTGGCCAC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
lh10 gja1b
Expression
Gene expression in Wild Types + CRISPR3-gja1b
No data available
Phenotype
Phenotype resulting from CRISPR3-gja1b
No data available
Phenotype of all Fish created by or utilizing CRISPR3-gja1b
Phenotype Fish Conditions Figures
caudal fin vein decreased diameter, abnormal gja1blh10/lh10 standard conditions Fig. 7 from Hyland et al., 2021
heart contraction decreased rate, abnormal gja1blh10/lh10 standard conditions Fig. 4 from Hyland et al., 2021
whole organism Ab1-gja1 labeling increased amount, abnormal gja1blh10/lh10 standard conditions Fig. 2 from Hyland et al., 2021
atrium Ab1-gja1 labeling increased amount, abnormal gja1blh10/lh10 standard conditions Fig. 5 from Hyland et al., 2021
fin gja1b expression increased amount, abnormal gja1blh10/lh10 physical alteration: fin Fig. 5 from Bhattacharya et al., 2020
heart gap junction increased amount, abnormal gja1blh10/lh10 standard conditions Fig. 5 from Hyland et al., 2021
heart elongated, abnormal gja1blh10/lh10 standard conditions Fig. 4 from Hyland et al., 2021
heart decreased size, abnormal gja1blh10/lh10 standard conditions Fig. 4 from Hyland et al., 2021
pericardium edematous, abnormal gja1blh10/lh10 standard conditions Fig. 4 from Hyland et al., 2021
cardiac ventricle Ab1-gja1 labeling increased amount, abnormal gja1blh10/lh10 standard conditions Fig. 5 from Hyland et al., 2021
caudal fin artery increased diameter, abnormal gja1blh10/lh10 standard conditions Fig. 7 from Hyland et al., 2021
fin increased length, abnormal gja1blh10/lh10 physical alteration: fin Fig. 6 with image from Bhattacharya et al., 2020
fin evx1 expression decreased distribution, abnormal gja1blh10/lh10 physical alteration: fin Fig. 5 from Bhattacharya et al., 2020
heart malformed, abnormal gja1blh10/lh10 standard conditions Fig. 4 from Hyland et al., 2021
caudal fin vasculature disorganized, abnormal gja1blh10/lh10 standard conditions Fig. 7 from Hyland et al., 2021
whole organism vegfaa expression decreased amount, abnormal gja1blh10/lh10 standard conditions Fig. 8 from Hyland et al., 2021
heart gap junction increased size, abnormal gja1blh10/lh10 standard conditions Fig. 5 from Hyland et al., 2021
caudal fin vasculature blood circulation disrupted, abnormal gja1blh10/lh10 standard conditions Fig. 7 from Hyland et al., 2021
whole organism gap junction decreased functionality, abnormal gja1blh10/lh10 standard conditions Fig. 5 from Hyland et al., 2021
intersegmental vessel increased diameter, abnormal gja1blh10/lh10; y1Tg standard conditions Fig. 6 from Hyland et al., 2021
Citations